Ravelcare IPO GMP: Day 2 IPO Live Updates

Posted by : sachet | Tue Dec 02 2025

The Ravelcare IPO GMP is ₹52 as of 2nd December 2025. It is a bookbuilding IPO of ₹24.10 crores. This is an entirely fresh issue of 19,00,000 shares. The issue will be listed on BSE and SME on its tentative listing date, 8th December 2025. The face value of Ravelcare IPO shares is ₹10 per share, and the IPO price band is ₹123 to ₹130 per share. Retail investors can bid for a minimum of 2 lots of 2,000 shares worth ₹2,52,000.

Table of Contents

Ravelcare IPO GMP Grey Market Premium

As of 2nd December 2025, the Ravelcare IPO GMP stands at ₹65 per share. Thus, the estimated listing price would be ₹195. This indicates that the estimated listing gain in this IPO could be 50.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Ravelcare IPO GMP updates.

GMP Date	IPO Price	GMP	Estimated Listing Price	Estimated Listing Gains
2-12-2025	₹130.00	₹65.00	₹195.00	50.00
1-12-2025	₹130.00	₹52.00	₹182.00	40.00%
30-11-2025	₹130.00	₹16.00	₹146.00	12.31%
29-11-2025	₹130.00	₹16.00	₹146.00	12.31%
28-11-2025	₹130.00	₹16.00	₹146.00	12.31%
27-11-2025	₹130.00	₹16.00	₹146.00	12.31%

Ravelcare IPO Details

IPO Open Date	1st December 2025
IPO Close Date	3rd December 2025
IPO Allotment Date	4th December 2025
Refund Initiation	5th December 2025
Face Value	₹10 per share
Price Band	₹123 to ₹130 per share
Lot Size	1,000 Shares
Issue Size	18,54,000 shares(aggregating up to ₹24.10 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE and SME
Listing Date	8th December 2025

Explanation

Ravelcare IPO: Ravelcare IPO Limited has declared an issue price band of ₹123.00 to ₹130.00 per share. With this IPO, the company allows retail investors to bid for at least two lots of 2,000 shares, each worth ₹2,60,000. The face value of Ravelcare IPO Limited shares is ₹10 per share. The shares of Ravelcare IPO Limited will be listed on BSE and SME on its tentative listing day, 8th December 2025. Scroll down to check GMP updates and Ravelcare IPO reviews.

Ravelcare IPO Objectives

The primary aim of the Ravelcare IPO is to raise ₹24.10 crores. On the other hand, Ravelcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Ravelcare IPO.

Marketing and advertising expenses toward enhancing the awareness and visibility of the brand
Setting up a new manufacturing facility located at Mauje-Peth in Amravati (“Proposed facility”)
To meet general corporate purposes

Ravelcare IPO Registrar

According to recent updates, Kfin Technologies Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Ravelcare IPO GMP, allotment, or refund, please contact the investor relations team at Kfin Technologies Private Limited at reachus@kfintech.com or 04067162222, 04079611000.

Ravelcare IPO Review

The Ravelcare IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Ravelcare Limited’s revenue increased by 14% from ₹22.28 crore in March 2024 to ₹25.30 crore in March 2025. Moreover, the company’s PAT increased by 5% from ₹5.02 crores to ₹5.26 crores. Investors can analyse other relevant factors and make a decision accordingly.

Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for additional ratings to get a clearer picture and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Ravelcare IPO or not.

Ravelcare IPO Limited Technicals

Key Indicators	Value
PE Ratio (Price-to-Earnings)	12.38
EPS (Earnings Per Share)	10.50
RoNW	50.77%
ROCE	68.32%
ROE	68.04%
EBITDA Margin	27.30%
Price to Book Value	6.29
Market Capitalisation	₹89.17 Cr.

The P/E ratio of Ravelcare Limited’s shares is 12.38, and its Earnings Per Share (EPS) is 10.50. Thus, the Ravelcare Limited IPO can deliver gains on its tentative listing day, 3rd December 2025

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Ravelcare IPO Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics.

Indicators	Pre-IPO	Post-IPO
PE Ratio	12.38	13.95
EPS	10.50	9.32

FAQs on Ravelcare IPO

What is the Ravelcare IPO GMP?

Currently, on 2nd December 2025, the Ravelcare IPO GMP (Grey Market Premium) stands at ₹65. This indicates that the estimated listing price could be ₹195 per share.

What is the issue price of Ravelcare IPO?

The Ravelcare IPO issue price band is set at ₹123 to ₹130 per share. Retail investors can apply for a minimum of 2 lots consisting of 2,000 shares worth ₹2,60,000. Moreover, HNIs are required to bid for a minimum of 3 lots (3,000 shares) worth ₹3,90,000.

Who is the registrar of Ravelcare IPO?

Kfin Technologies Limited is the registrar for the Ravelcare IPO, awaiting to manage the allotment process and initiate refunds. For any queries regarding the Ravelcare allotment and refund, you can contact Kfin Technologies Limited at reachus@kfintech.com or 04067162222, 04079611000.

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Ravelcare IPO, download the Ravelcare IPO RHP and Ravelcare IPO DRHP. Conduct your research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.